Sunways

What Sunways does

Sunways (Sunways India Pvt Ltd, headquartered in Mumbai) is a 70-plus-year-old, family-controlled Indian specialty pharmaceutical company founded in 1951 by Late Mr. Kantilal Shroff, manufacturing and marketing sterile ophthalmic and ENT formulations across India. Its portfolio spans more than 100 SKUs covering antibiotic eye drops, anti-glaucoma medications, NSAIDs, lubricants for dry eye, antioxidants and ocular nutrition supplements, steroids, combination antibiotic-steroid preparations, intra-cameral surgical aids, ENT products (ear drops, nasal sprays, decongestants), and the Vera Plugs medical-device line for dry-eye treatment. Manufacturing is carried out across three certified facilities in Ahmedabad (sterile plant acquired 1992), Sarigam, Gujarat (oral liquids, acquired 1995) and Dholka, Ahmedabad (Sunways Rohto JV plant, WHO-GMP and ISO certified), with the company reinvesting roughly 10% of turnover in R&D focused on novel drug-delivery systems.

The company operates a sales-led go-to-market model built around a dedicated field force plus senior-management engagement with the ophthalmic faculty across India, supplemented by government tendering for institutional supply. Revenue is generated from one-time unit sales of branded pharmaceutical products (no subscription or licensing model is disclosed), with ophthalmologists and ENT specialists as the two named end-customer segments. Strategically, Sunways has used partnerships and acquisitions to broaden its base: a 2013 JV with Japan's Rohto Pharmaceuticals (40% equity in Sunways Rohto Pvt Ltd), a JV with US-based Lacrivera for punctal occluders, the February 2021 acquisition of Inor Medical Products, a Rs 120 crore minority investment by InvAscent in November 2022 earmarked for capacity, international growth and M&A, and the May 2026 acquisition of Indoco Remedies' ophthalmic business for Rs 110 crore. Management remains family-led, with Pankaj Shroff as Chairman & Managing Director, Anupam Shroff as COO, and Bhadresh Shroff as CFO; the company is privately held with no public listing.

Name

Sunways

Legal name

Sunways (India) Private Limited

Website

https://sunways.com

Company type

Private

Founded year

1951

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Sunways is a Mumbai-based, family-controlled Indian pharmaceutical company founded in 1951, manufacturing and marketing sterile ophthalmic and ENT formulations, medical devices and ocular nutrition products for ophthalmologists and ENT specialists across India via a field-sales model and government tendering.

Ownership category

akta.pro rank

Product category

Ophthalmic Pharmaceuticals

NAICS

Ophthalmic Goods Manufacturing (339115), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLAIACAK

Ophthalmology Specialty Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Specialty Pharmaceuticals

SECONDARYHLAIAAAL

Ophthalmology Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYHLAIABAF

Ophthalmic & Otic Generics

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

SECONDARYHLAIADAF

Eye, Ear & Nasal Care

Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines

Keywords

• Ophthalmic formulations
• ENT pharmaceuticals
• Sterile eye drops
• Dry eye treatments
• Intra-cameral solutions

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Pharmaceutical Products Sales: Manufacturing and marketing of sterile ophthalmic and ENT formulations, oral medications including capsules and syrups. Revenue generated from sale of pharmaceutical products across multiple therapeutic areas including antibiotics, antioxidants, anti-glaucoma, lubricants, and ENT products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Sunways manufactures and markets a wide range of sterile pharmaceutical formulations focused on ophthalmology and ENT (ear, nose, throat). The portfolio spans eye drops, eye ointments, small volume parenterals, intra-cameral surgical formulations, oral capsules and syrups across therapeutic areas including antibiotics, anti-glaucoma, anti-allergics, lubricants, antioxidants, NSAIDs, steroids, antivirals, mydriatics, and antifungals. The company also offers medical devices such as Vera Plugs punctal occluders for chronic dry eye treatment.

Product overview

Sunways is a pharmaceutical company specializing in ophthalmology and ENT (Ear, Nose, Throat) products. The company manufactures and markets a wide range of sterile ophthalmic formulations including antibiotics (Chlorosun, Estocin, Gentamide, Nebracin, Occumox, Oflo, Gatsun), antioxidants and nutritional supplements (Astagold, Eye Vital, Eye Vital LX, Ofusion, Lacriguard), combination antibiotic-steroid formulations, anti-glaucoma medications (Brio, Dorsun, Travosun, Carpinol, Timanol), NSAIDs (Algic, Xinep, Z-Brom), lubricants for dry eye (Just Tears, XLHA, Lacrigel), and diagnostic aids. The ENT portfolio includes ear drops (Otoflu, Myclin, Audisol), nasal products (Synox, Netiwash), and systemic medications. Additionally, Sunways offers medical devices including Vera Plugs punctal occlusion products for dry eye treatment. The company operates through its group entities including Sunways (India) Private Limited for ophthalmic and ENT products, Sunways Laboratories Private Limited for oral medications, and Sunways Rohto Private Limited for sterile preparations.

Differentiator

Problem solved

Functional benefit

Brands

• Vera Plugs: Punctal plugs for treatment of chronic dry eye, offered in partnership with Lacrivera (US-based). Includes Vera C7 collagen inserts, Vera 90 synthetic extended inserts, and permanent silicone plugs.

Products and services

• Antibiotic Ophthalmic Drops

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered major, flagship and core.

• Indoco RemediesmajorStrategic or Co-development Partner · 1 May 2026Indoco Remedies sold its ophthalmic business to Sunways India for Rs 110 crore. This represents a strategic acquisition of ophthalmic business assets.
• Rohto Pharmaceuticals JapanflagshipStrategic or Co-development Partner · 1 November 2013Rohto Pharmaceuticals Japan, a public listed company headquartered in Osaka, acquired 40% equity stake in Deep Care Health Private Limited (now Sunways Rohto Pvt. Ltd). The JV focuses on manufacturing prescription and OTC ophthalmological products (eye drops, eye wash, ophthalmological injections) and dermatological products. Rohto brings world-class manufacturing capabilities from Vietnam, Indonesia, Japan, and USA.
• LacriveracoreTechnology or IntegrationJoint venture with US-based MNC Lacrivera, a division of Stephens Instruments, to offer Vera Plugs Punctal occluder products for the treatment of dry eye. The partnership offers complete range of innovative products designed to provide unparalleled retention and enhanced patient comfort.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Entod Pharmaceuticals: India-based specialty pharmaceutical company focused on ophthalmology, ENT and dermatology formulations with a similar field-sales model targeting ophthalmologists — directly comparable product category, customer base and delivery mechanism to Sunways.
• Centaur Pharmaceuticals: Indian pharma manufacturer with an established ophthalmic and ENT product franchise sold through field sales to specialists in India — overlapping therapeutic categories, dosing formats and prescriber customers as Sunways.
• Ajanta Pharma: Indian specialty pharma with a branded ophthalmic portfolio including antibiotics, anti-allergy and lubricants distributed through field force engagement with ophthalmologists — directly comparable channel and therapeutic coverage.
• FDC Limited: Indian pharma company with a significant ophthalmic and ENT formulations range marketed through a field force to specialists — closely comparable product mix, geography and prescription-driven GTM.

Broad incumbents

• Lupin: Large Indian pharmaceutical major with an ophthalmic and specialty division that competes for shelf and prescriber attention; broader portfolio and global footprint but overlapping ophthalmology SKUs and channel model.
• Cipla: Major Indian pharmaceutical company with an established ophthalmology franchise spanning anti-infectives, anti-glaucoma and dry-eye products — overlapping categories with substantially wider therapeutic breadth and resources than Sunways.
• Sun Pharmaceutical Industries: India's largest pharma company with ophthalmology offerings (anti-glaucoma, allergy, dry eye) distributed nationally — overlapping product category and prescriber channel but competing from a much larger scale.
• Alcon: Global leader in eye care covering pharmaceuticals, surgical devices and vision care — competing with Sunways in ophthalmic pharmaceuticals and intra-cameral surgicals, particularly in India's premium segment.
• Bausch + Lomb: Global eye-health specialist with an ophthalmic pharmaceutical portfolio spanning anti-infectives, anti-inflammatories and glaucoma therapies — overlaps with Sunways' therapeutic categories and increasingly with surgical adjuvants.
• Glenmark Pharmaceuticals: Indian pharmaceutical major with ophthalmology formulations in its specialty portfolio — broader in scale and therapeutic coverage but competing with Sunways in India for ophthalmologist prescriptions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sunways-india-pvt-ltd-

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sunways